During the past decade, Ishida Clinic of IBD and Gastroenterology conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 6 clinical trials were completed, i.e. on average, 54.5% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 6 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ishida Clinic of IBD and Gastroenterology" are "Ulcerative Colitis" (7 trials), "Crohn's Disease" (3 trials), "Colitis, Ulcerative" (1 trials) and "Crohns Disease" (1 trials). Many other conditions were trialed in "Ishida Clinic of IBD and Gastroenterology" in a lesser frequency.

Most popular intervention types in "Ishida Clinic of IBD and Gastroenterology" are "Drug" (10 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Ontamalimab" (4 trials), "Mirikizumab" (2 trials), "25 mg Ontamalimab" (1 trials) and "75 mg Ontamalimab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ishida Clinic of IBD and Gastroenterology" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Ishida Clinic of IBD and Gastroenterology". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ishida Clinic of IBD and Gastroenterology, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Ishida Clinic of IBD and Gastroenterology, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".